Dawid Schellingerhout, MBChB, BSc (Hons) (Physiology), CPE, MBA
Department of Neuroradiology, Division of Diagnostic Imaging
About Dr. Schellingerhout
Dr. Schellingerhout joined M D Anderson in 2004 from Massachusetts General Hospital and Harvard Medical School. He regularly publishes in the molecular and neurological imaging literature, and regularly presents data at national and international scientifice meetings.
Dr. Schellingerhout’s research centers on investigating the Nervous System with molecular and novel imaging technologies. His group has developed a set of molecular imaging agents for neurography, the imaging of nerve tissue by means of molecular imaging, and has investigated several preclinical models in preparation to applying this technology to humans.
He also has a patient-centered program investigating the correlations between imaging and biological findings in patients with gliomas, in collaboration with Neurosurgery and Neuropathology, and involving advanced MR imaging directed biopsies correlated to state-of-the-art pathological and biological assessments of harvested patient brain tissues He is also investigating the clinical uses of Dual Energy CT and Phase Sensitive MR in the characterization of cerebral lesions in a human imaging trial.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Member, Department of Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Molecular Imaging of novel gene and cell based therapies, particularly for Central Nervous System (CNS) conditions Non-invasive mapping of therapeutic gene delivery Assessment of therapeutic gene expression by imaging Pharmacological manipulation of gene therapy vector distribution Focus ultrasound for the disruption of the blood brain barrier Assessment of PET agents for the delineation of brain tumors
Education & Training
Degree-Granting Education
| 2022 | Rice University, Jones School of Business, Houston, Texas, US, Executive Masters of Business Administration, MBA |
| 1994 | University of Pretoria, Faculty of Medicine, Pretoria, ZA, Physiology, BSc Hons (cum laude) |
| 1993 | University of Pretoria, Faculty of Medicine, Pretoria, ZA, Medicine, MBChB |
Postgraduate Training
| 2013-null | Certifying Commission in Medical Management, Certified Physician Executive, American College of Physician Executives, Tampa, Florida |
| 2000-2001 | Clinical Fellowship, Neuroradiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts |
| 1999-2000 | Clinical Residency, Neuroradiology Focus Year, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts |
| 1996-2000 | Clinical Residency, Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts |
| 1995-1996 | General Practice, Cardiology/General Medicine, One Military Hospital, Pretoria |
| 1994-1994 | Clinical Internship, Surgery, Medicine, Anesthesiology, Pediatrics, One Military Hospital, Pretoria |
Board Certifications
| 2002 | American Board of Radiology, Certificate of Additional Qualification in Neuroradiology |
| 2000 | American Board of Radiology, Diagnostic Radiology (valid indefinitely) |
Experience & Service
Academic Appointments
Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Associate Professor, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2022
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018
Associate Professor, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018
Assistant Professor, Department of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011
Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011
Instructor, Department of Diagnostic Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2001 - 2004
Administrative Appointments/Responsibilities
Director of Research, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021
Head of Schellingerhout Lab, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - Present
Other Appointments/Responsibilities
TrueFidelity image quality generated on EVO CT system, GE Healthcare, Houston, TX, 2019 - 2019
Gadolinium related T1 signal in the brain, Guerbet LLC Advisory Board, Washington, DC, 2016 - 2016
Imaging Consultant on Gliasite bradytherapy device clinical trial, Proxima Therapeutics, Orlando, FL, 2004 - 2004
Attending Radiologist, Division of Emergency Radiology, Massachusetts General Hospital, Boston, MA, 2004 - 2004
Member, Radiology Associates Nominating Committee for the Executive Committee at Massachusetts General Hospital, Boston, MA, 2003 - 2004
Attending Radiologist, Division of Neuroradiology, Massachusetts General Hospital, Boston, MA, 2001 - 2004
Research Associate, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA, 1996 - 2004
Medical Officer in Cardiology, Medicine and Radiology, One Military Hospital, Pretoria, 1995 - 1996
Post Graduate Student in Laboratory of Margaretha Viljoen, PhD, Department of Physiology, University of Pretoria, Pretoria, 1994 - 1995
General Medical Assistant, Pretoria Academic Hospital, Emergency Department, Pretoria, 1987 - 1992
Institutional Committee Activities
Committee Member, DI-RFC Awards & Honors Committee, 2022 - Present
Member, Photon Counting CT Task Force, 2021 - Present
Member, Diagnostic Imaging Research Functional Committee, 2021 - Present
Member, Brain Tumor Center Tissue Oversight Committee, 2021 - Present
Member, Diagnostic Imaging Promotion and Tenure Committee, 2021 - Present
Member, Brain Tumor Center, Tissue Utilization Committee, 2021 - 2021
Non Physicist Member, Medical Physics Graduate Program Steering Committee, 2018 - 2021
Member, Nuclear Medicine Faculty Search Committee, 2016 - Present
Member, Faculty Appeals Panel, 2014 - Present
Member, Diagnostic Imaging Equipment Selection Committee, 2014 - Present
Member, Imaging Physics Section Chief Search Committee, 2013 - Present
Member, MR Contrast Agent Selection Subcommittee, 2013 - Present
Member, Diagnostic Imaging Faculty Functional Committee, 2013 - 2016
Member, Nuclear Medicine Faculty Search Committee, 2011 - 2014
Member, Diagnostic Imaging Informatics Advisory Group, 2011 - Present
Member, Survivorship Research Advisory Committee, 2011 - Present
Member, MR Clinical Utilization Committee, 2008 - Present
Honors & Awards
| Winner (placed 43rd countrywide), Youth Science Olympiad, South Africa | |
| Graduated High School with Seven Distinctions | |
| University Merit Award, University of Pretoria | |
| Medical Degree cum laude, University of Pretoria | |
| Postgraduate Degree in Physiology cum laude, University of Pretoria | |
| Grant Recipient, NAVKOM D.O.O | |
| Resident Research Trainee Prize for abstract entitled: “Gene Therapy to Somatic Organs: Using imaging to assess pharmacological manipulations of viral mass distribution”, Radiological Society of North America | |
| Norman E. Leeds Award for presentation entitled "Molecular Imaging in Neuroradiology", Eastern Neuroradiological Society | |
| Honorary Member, Bluegrass Radiological Society |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Dagher SA, Liu HL, Ozkara BB, Calle S, Kaya D, Gule-Monroe MK, Chasen NN, Schellingerhout D, Learned KO, Shah KB, Johnson JM, Sun J, Schomer DF, Kumar VA, Wintermark M, Majd NK, Nam JY, Chen MM. The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study. AJR Am J Roentgenol None(None):1-15, 2024. PMID: 39140632.
- Gwak DS, Ryu WS, Schellingerhout D, Chung J, Kim HR, Jeong SW, Kim BJ, Kim JT, Hong KS, Park JM, Park MS, Choi KH, Park TH, Lee K, Park SS, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Lee JS, Bae HJ, Kim DE. Effects of white matter hyperintensity burden on functional outcome after mild versus moderate-to-severe ischemic stroke. Sci Rep 14(1):22567, 2024. PMID: 39343768.
- Kim H, Ryu WS, Schellingerhout D, Park J, Chung J, Jeong SW, Gwak DS, Kim BJ, Kim JT, Hong KS, Lee KB, Park TH, Park JM, Kang K, Cho YJ, Lee BC, Yu KH, Oh MS, Lee SJ, Cha JK, Kim DH, Lee J, Park MS, Bae HJ, Kim DE. Automated segmentation of MRI white matter hyperintensities in 8,421 patients with acute ischemic stroke. AJNR Am J Neuroradiol. e-Pub 2024. PMID: 39013565.
- Lai SY, Sandulache VC, Schellingerhout D, Fuller CD, Chen Y, Walker CM, Bankson JA. First-in-Human Hyperpolarized MRI for Tumor Metabolism in HNSCC. JAMA Otolaryngol Head Neck Surg 150(7):628-630, 2024. e-Pub 2024. PMID: 38780963.
- Ryu WS, Schellingerhout D, Lee H, Lee KJ, Kim CK, Kim BJ, Chung JW, Lim JS, Kim JT, Kim DH, Cha JK, Sunwoo L, Kim D, Suh SI, Bang OY, Bae HJ, Kim DE. Deep Learning-Based Automatic Classification of Ischemic Stroke Subtype Using Diffusion-Weighted Images. J Stroke 26(2):300-311, 2024. e-Pub 2024. PMID: 38836277.
- Jha PK, Walker C, Mitchell D, Oden JT, Schellingerhout D, Bankson JA, Fuentes DT. Mutual-information based optimal experimental design for hyperpolarized C13-pyruvate MRI. Sci Rep 13(1):18047, 2023. e-Pub 2023. PMID: 37872226.
- Ryu WS, Chung J, Schellingerhout D, Jeong SW, Kim HR, Park JE, Kim BJ, Kim JT, Hong KS, Lee K, Park TH, Park SS, Park JM, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Park MS, Choi KH, Lee J, Bae HJ, Kim DE. Biological Mechanism of Sex Difference in Stroke Manifestation and Outcomes. Neurology 100(24):e2490-e2503, 2023. e-Pub 2023. PMID: 37094993.
- Celaya A, Actor JA, Muthusivarajan R, Gates E, Chung C, D|| S, Riviere B, Fuentes D. PocketNet: A Smaller Neural Network For Medical Image Analysis. IEEE Trans Med Imaging PP(4):1172-1184, 2023. e-Pub 2022. PMID: 36427285.
- Jang HJ, Schellingerhout D, Kim J, Chung J, Kim DE. Towards a biomarker for acute arterial thrombosis using complete blood count and white blood cell differential parameters in mice. Sci Rep 13(1):4043, 2023. e-Pub 2023. PMID: 36899036.
- ENE Group MO, Sahin O, Wahid KA, Taku N, He R, Naser MA, Mohamed ASR, Mäkitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chen MM, Chronowski GM, Diaz EM, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache V, Schellingerhout D, Shah SJ, Sikora AG, Wintermark M, Fuller CD. Multi-Specialty Expert Physician Identification of Extranodal Extension in Computed Tomography Scans of Oropharyngeal Cancer Patients: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2023. e-Pub 2023. PMID: 36865096.
- Kang DW, Park GH, Ryu WS, Schellingerhout D, Kim M, Kim YS, Park CY, Lee KJ, Han MK, Jeong HG, Kim DE. Strengthening deep-learning models for intracranial hemorrhage detection: strongly annotated computed tomography images and model ensembles. Front Neurol 14:1321964, 2023. e-Pub 2023. PMID: 38221995.
- Gates EDH, Suki D, Celaya A, Weinberg JS, Prabhu SS, Sawaya R, Huse JT, Long JP, Fuentes D, Schellingerhout D. Cellular Density in Adult Glioma, Estimated with MR Imaging Data and a Machine Learning Algorithm, Has Prognostic Power Approaching World Health Organization Histologic Grading in a Cohort of 1181 Patients. AJNR Am J Neuroradiol 43(10):1411-7, 2022. e-Pub 2022. PMID: 36109124.
- Gates EDH, Celaya A, Suki D, Schellingerhout D, Fuentes D. An efficient magnetic resonance image data quality screening dashboard. J Appl Clin Med Phys 23(4):e13557, 2022. e-Pub 2022. PMID: 35148034.
- Debnam JM, Chi TL, Kwon M, Sun J, Schellingerhout D, Golant BT, Ahmed S, Perrier ND, Vu T. Distinguishing Intrathyroid Parathyroid Adenoma from Colloid Nodules and Papillary Thyroid Carcinomas Using Multiphasic Multidetector Computed Tomography. J Comput Assist Tomogr 46(5):808-814, 2022. e-Pub 2022. PMID: 36103680.
- Ryu WS, Schellingerhout D, Hong KS, Jeong SW, Kim BJ, Kim JT, Lee KB, Park TH, Park SS, Park JM, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Park MS, Choi KH, Nahrendorf M, Lee J, Bae HJ, Kim DE. Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes. Ann Neurol 90(5):763-776, 2021. e-Pub 2021. PMID: 34536234.
- Baiomy A, Schellingerhout D, Chapin B, Weinberg JS, Raza SM, Macapinlac H, Ravizzini G. Rate of Incidental Central Nervous System Meningioma Detected in Patients Undergoing 18F-fluciclovine PET/CT Imaging for Evaluation of Prostate Cancer. Nucl Med Commun 42(7):755-762, 2021. PMID: 33741867.
- Schellingerhout D, Jacobsen M, Le Roux L, Johnson JM, Baladandayuthapani V, Hwang K, Hazle J, Cody D. The Calcium vs Hemorrhage Trial: Developing Diagnostic Criteria for Chronic Intracranial Susceptibility Lesions Using Single Energy CT, Dual Energy CT, and Quantitative Susceptibility Mapping. Invest Radiol 56(6):385-393, 2021. PMID: 33534507.
- Gates EDH, Weinberg JS, Prabhu SS, Lin JS, Hamilton J, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes DT, Schellingerhout D. Estimating Local Cellular Density in Glioma Using MR Imaging Data. AJNR Am J Neuroradiol 42(1):102-108, 2021. e-Pub 2020. PMID: 33243897.
- Kim J, Jang HJ, Schellingerhout, Lee SK, Kim H, Kim YD, Lee KY, Choi HY, Cho HJ, Jang SS, Jeon S, Kwon IC, Kim K, Ryu WI, Nathrendorf M, Choi S, Kim DE. Short-term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State. Annals of Neurology 89(3):444-458, 2020. PMID: 33219556.
- Elshikh M, Schellingerhout D, Rayan J, Taher A, Elsayes AK, Mujtaba B, Garg N. Disease Characteristics, Radiologic Patterns, Comorbid Diseases, and Ethnic Differences in 32 Patients With Rosai-Dorfman Disease. J Comput Assist Tomogr 44(3):450-461, 2020. PMID: 31972751.
- Le Roux LG, Qiu X, Jacobsen MC, Pagel MD, Gammon ST, Piwnica-Worms DR, Schellingerhout D. Axonal transport as an in vivo biomarker for retinal neuropathy. Cells 9(5):1298, 2020. PMID: 32456061.
- Kim J, Jang HJ, Schellingerhout D, Kang JW, Choi S, Oh H, Kim EJ, Lee SK, Lee JS, Kwon IC, Kim K, Koh YJ, Ryu WS, Kim DE. Effects of exercise training and detraining on atheromatous matrix metalloproteinase activity in mice. Atherosclerosis, 2020. PMID: 32182440.
- Debnam JM, Guha-Thakurta N, Sun J, Wei W, Zafereo ME, Cabanillas ME, Buisson NM, Schellingerhout D. Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT. AJNR Am J Neuroradiol, 2020. PMID: 32327435.
- Gates EDH, Lin JS, Weinberg JS, Prabhu SS, Hamilton J, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes DT, Schellingerhout D. Imaging-Based Algorithm for the Local Grading of Glioma. AJNR Am J Neuroradiol, 2020. PMID: 32029466.
- Kim J, Lee SK, Schellingerhout D, Nahrendorf M, Kim K, Kim J, Kim DE. Spectroscopic Assessment of Gold Nanoparticle Biodistribution Using Surface Plasmon Resonance Phenomena. ACS Biomater Sci Eng 5(12):6389-6394, 2019. PMID: 33417791.
- Kim DE, Schellingerhout D, Ryu WS, Park JH, Lee SK, Kim D, Bae HJ. Supratentorial Cerebral Arterial Territories for Computed Tomograms: A Mapping Study in 1160 Large Artery Infarcts. Sci Rep 9(1):11708, 2019. PMID: 31406206.
- Ryu WS, Schellingerhout D, Ahn HS, Park SH, Hong KS, Jeong SW, Park MS, Choi KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Nah HW, Lee SJ, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Park SS, Smith EE, Lee J, Bae HJ, Kim DE. White matter hyperintensity load on stroke recurrence and mortality at 1 year after ischemic stroke. Neurology 93(6):e578-e589, 2019. PMID: 31308151.
- Jacobsen MC, Cressman ENK, Tamm EP, Baluya DL, Duan X, Cody DD, Schellingerhout D, Layman RR. Dual-Energy CT: Lower Limits of Iodine Detection and Quantification. Radiology 292(2):414-419, 2019. PMID: 31237496.
- Michel KA, Zieliński R, Walker CM, Le Roux L, Priebe W, Bankson JA, Schellingerhout D. Hyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma. Radiology, 2019. PMID: 31385757.
- Gates EDH, Yang J, Fukumura K, Lin JS, Weinberg JS, Prabhu SS, Long L, Fuentes D, Sulman EP, Huse JT, Schellingerhout D. Spatial Distance Correlates With Genetic Distance in Diffuse Glioma. Front Oncol 9:676, 2019. PMID: 31417865.
- Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V. Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol 142(3):409, 2019. PMID: 30968268.
- Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro-Oncology 21(4):527-536, 2019. PMID: 30657997.
- Kim DE, Ryu WS, Schellingerhout D, Jeong HG, Kim P, Jeong SW, Park MS, Choi KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Nah HW, Lee SJ, Kim JG, Hong KS, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Park SS, Lee YS, Bae HJ. Estimation of Acute Infarct Volume with Reference Maps: A Simple Visual Tool for Decision Making in Thrombectomy Cases. Journal of Stroke 21(1):69-77, 2019. PMID: 30732442.
- Vu TH, Schellingerhout D, Guha-Thakurta N, Sun J, Wei SW, Kappadath C, Perrier N, Kim EE, Rohren E, Chuang HH, Wong FC. Solitary Parathyroid Adenoma Localization inTechnetium Tc99m Sestamibi SPECT CT and Multiphase Multidetector 4D CT. AJNR 40(1):142-149, 2019. PMID: 30523145.
- Kim DE, Park JH, Schellingerhout D, Rye WS, Lee SK, Jang MU, Jeong SW, Na JY, Park JE, Lee EJ, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Lee BC, Yu KH, Oh MS, Hong KS, Cho YJ, Park JM, Kang K, Park TH, Lee KB, Park KJ, Choi HK, Lee JY, Bae HJ. Supratentorial Cerebral Arterial Territories: A Mapping Study in 1160 Large Artery Infarcts. JAMA Neurol 76(1):72-80, 2019. PMID: 30264158.
- Ryu WS, Schellingerhout D, Ahn HS, Park SH, Hong KS, Jeong SW, Park MS, Choi KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Nah HW, Lee SJ, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Park SS, Smith EE, Lee J, Bae HJ, Kim DE. Hemispheric Asymmetry of White Matter Hyperintensity in Association With Lacunar Infarction. Journal of The American Heart Association 7(22):e010653, 2018. PMID: 30571500.
- Jacobsen MC, Schellingerhout D, Wood CA, Tamm EP, Godoy MC, Sun J, Cody DD. Intermanufacturer comparison of dual-energy computed tomography iodine quantification and monochromatic attenuation: a phantom study. Radiology 287(1):170896, 2018. e-Pub 2017. PMID: 29185902.
- Ryu WS, Bae EK, Park SH, Jeong SW, Schellingerhout D, Nahrendorf M, Kim DE. Increased Left Ventricular Filling Pressure and Arterial Occlusion in Stroke Related to Atrial Fibrillation. J Stroke Cerebrovasc Dis. e-Pub 2018. PMID: 29310958.
- Shon SM, Jang HJ, Schellingerhout D, Kim JY, Ryu WS, Lee SK, Kim J, Park JY, Oh JH, Kang JW, Je KH, Park JE, Kim K, Kwon IC, Lee J, Nahrendorf M, Park JH, Kim DE. Cytokine Response to Diet and Exercise Affects Atheromatous Matrix Metalloproteinase-2/9 Activity in Mice. Circ J 81(10):1528-1536, 2017. e-Pub 2017. PMID: 28883215.
- Kim DE, Kim JY, Schellingerhout D, Ryu JH, Lee SK, Jeon S, Lee JS, Kim J, Jang HJ, Park JE, Kim EJ, Kwon IC, Ahn CH, Nahrendorf M, Kim K. Quantitative Imaging of Cerebral Thromboemboli In Vivo: The Effects of Tissue-Type Plasminogen Activator. Stroke 48(5):1376-1385, 2017. PMID: 28432262.
- Lin JS, Fuentes DT, Chandler A, Prabhu SS, Weinberg JS, Baladandayuthapani V, Hazle JD, Schellingerhout D. Performance Assessment for Brain MR Imaging Registration Methods. AJNR Am J Neuroradiol 38(5):973-980, 2017. e-Pub 2017. PMID: 28279984.
- Je KH, Ryu WS, Lee SK, Kim EJ, Kim JY, Jang HJ, Park JE, Nahrendorf M, Schellingerhout D, Kim DE. Green-channel autofluorescence imaging: A novel and sensitive technique to delineate infarcts. J Neurosci Methods 279:22-32, 2017. PMID: 28104485.
- Li CH, Chen FH, Schellingerhout D, Lin YS, Hong JH, Liu HL. Flow versus permeability weighting in estimating the forward volumetric transfer constant (Ktrans) obtained by DCE-MRI with contrast agents of differing molecular sizes. Magn Reson Imaging 36:105-111, 2017. PMID: 27989901.
- Nute JL, Jacobsen MC, Chandler A, Cody DD, Schellingerhout D. Dual-energy computed tomography for the characterization of intracranial hemorrhage and calcification: a systematic approach in a phantom system. Invest Radiol 52(1):30-41, 2017. PMID: 27379697.
- Ryu WS, Woo SH, Schellingerhout D, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Stroke outcomes are worse with larger leukoaraiosis volumes. Brain 140(Pt 1):158-170, 2017. PMID: 28008000.
- Shah AR, Muzzafar T, Assi R, Schellingerhout D, Estrov Z, Tamamyan G, Kantarjian H, Daver N. Hemophagocytic lymphohistiocytosis in adults: An under recognized entity. BBA Clin 7:36-40, 2016. PMID: 28070498.
- Kim DE, Kim JY, Lee SK, Ryu JH, Kwon IC, Ahn CH, Kim K, Schellingerhout D. Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli. J Vis Exp 25(115), 2016. PMID: 27768026.
- Ryu WS, Schellingerhout D, Jeong SW, Nahrendorf M, Kim DE. Association between Serum Lipid Profiles and Early Neurological Deterioration in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis 25(8):2024-2030, 2016. PMID: 27256172.
- Muzzafar S, Rhines LD, Bruner J, Schellingerhout D. Intradural extramedullary Ewing tumor of the lumbar spine. Radiol Case Rep 5(4):421, 2015. PMID: 27307878.
- Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, Chou PC, Rao A, Yeung SC, Lee MH, Schellingerhout D, Conrad CA, Malloy C, Sherry AD, Lai SY, Hazle JD. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res 75(22):4708-4717, 2015. PMID: 26420214.
- Kim JY, Ryu JH, Schellingerhout D, Sun IC, Lee SK, Jeon S, Kim J, Kwon IC, Nahrendorf M, Ahn CH, Kim K, Kim DE. Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles. Theranostics 5(10):1098-1114, 2015. PMID: 26199648.
- Nute JL, Le Roux L, Chandler AG, Baladandayuthapani V, Schellingerhout D, Cody DD. Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-energy computed tomography in a phantom system. Invest Radiol 50(1):9-16, 2015. PMID: 25162534.
- Ryu WS, Woo SH, Schellingerhout D, Chung MK, Kim CK, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Grading and interpretation of white matter hyperintensities using statistical maps. Stroke 45(12):3567-3575, 2014. PMID: 25388424.
- Le Roux LG, Bredow S, Grosshans D, Schellingerhout D. Molecular imaging detects impairment in the retrograde axonal transport mechanism after radiation induced spinal cord injury. Mol Imaging Biol 16(4):504-510, 2014. PMID: 24395625.
- Park JY, Lee SK, Kim JY, Je KH, Schellingerhout D, Kim DE. A new micro-computed tomography-based high-resolution blood-brain barrier imaging technique to study ischemic stroke. Stroke 45(8):2480-2484, 2014. PMID: 25013021.
- Ahmed S, Hamilton J, Colen R, Schellingerhout D, Vu T, Rao G, McAleer MF, Mahajan A. Change in postsurgical cavity size within the first 30 days correlates with extent of surrounding edema: consequences for postoperative radiosurgery. J Comput Assist Tomogr 38(3):457-460, 2014. PMID: 24681852.
- Raslan O, Debnam JM, Ketonen L, Kumar AJ, Schellingerhout D, Wang J. Stereoscopic visualization of diffusion tensor imaging data: a comparative survey of visualization techniques. Radiol Res Pract. e-Pub 2013. PMID: 24251037.
- Shin IJ, Shon SM, Schellingerhout D, Park JY, Kim JY, Lee SK, Lee DK, Lee HW, Ahn BC, Kim K, Kwon IC, Kim DE. Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out mice. PLoS One 8(9):e73451, 2013. PMID: 24069197.
- Walker CM, Lee J, Ramirez MS, Schellingerhout D, Millward S, Bankson JA. A catalyzing phantom for reproducible dynamic conversion of hyperpolarized [1-13C]-pyruvate. PLoS One 8(8):e71274, 2013. PMID: 23977006.
- Noh SM, Choi WJ, Kang BT, Jeong SW, Lee DK, Schellingerhout D, Yeo JS, Kim DE. Complementarity between (18) F-FDG PET/CT and Ultrasonography or Angiography in Carotid Plaque Characterization. J Clin Neurol 9(3):176-185, 2013. PMID: 23894241.
- Shon SM, Choi Y, Kim JY, Lee DK, Park JY, Schellingerhout D, Kim DE. Photodynamic therapy using a protease-mediated theranostic agent Reduces cathepsin-B activity in mouse atheromata in vivo. Arterioscler Thromb Vasc Biol 33(6):1360-1365, 2013. PMID: 23539220.
- Kim DE, Kim JY, Sun IC, Schellingerhout D, Lee SK, Ahn CH, Kwon IC, Kim K. Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. Ann Neurol 73(5):617-625, 2013. PMID: 23495101.
- Shawa H, Busaidy NL, Schellingerhout D, Habra MA. Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib. BMJ Case Rep. e-Pub 2013. PMID: 23682094.
- Hunter GJ, Schellingerhout D, Vu TH, Perrier ND, Hamberg LM. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology 264(3):789-795, 2012. PMID: 22798226.
- Schellingerhout D, LeRoux LG, Hobbs BP, Bredow S. Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging. PLoS One 7(9):e45776, 2012. PMID: 23029238.
- Kim JY, Park JH, Jeong SW, Schellingerhout D, Park JE, Lee DK, Choi WJ, Chae SL, Kim DE. High levels of remnant lipoprotein cholesterol is a risk factor for large artery atherosclerotic stroke. J Clin Neurol 7(4):203-209, 2011. PMID: 22259616.
- Kim DE, Kim JY, Nahrendorf M, Lee SK, Ryu JH, Kim K, Kwon IC, Schellingerhout D. Direct thrombus imaging as a means to control the variability of mouse embolic infarct models: the role of optical molecular imaging. Stroke 42(12):3566-3573, 2011. PMID: 22020025.
- Lee DK, Choi Y, Shon SM, Schellingerhout D, Park JE, Kim DE. Atorvastatin and clopidogrel interfere with photosensitization in vitro. Photochem Photobiol Sci 10(10):1587-1592, 2011. PMID: 21748161.
- Shah KB, Guha-Thakurta N, Schellingerhout D, Madewell JE, Kumar AJ, Costelloe CM. Comparison of gadolinium-enhanced fat- saturated T1-weighted FLAIR and fast spin-echo MRI of the spine at 3 T for evaluation of extradural lesions. AJR Am J Roentgenol 197(3):697-703, 2011. PMID: 21862814.
- Vu TH, Guha-Thakurta N, Harrell RK, Ahmed S, Kumar AJ, Johnson VE, Perrier ND, Hamberg LM, Hunter GJ, Schellingerhout D. Imaging characteristics of hyperfunctioning parathyroid adenomas using multiphase multidectector computed tomography: a quantitative and qualitative approach. J Comput Assist Tomogr 35(5):560-567, 2011. PMID: 21926850.
- Wu J, Langford LA, Schellingerhout D, Guha-Thakurta N, Tummala S, Weinberg JS, Puduvalli VK. Progressive multifocal leukoencephalopathy in a patient with glioblastoma. J Neurooncol 103(3):791-796, 2011. PMID: 21120583.
- Ong SS, Bruner J, Schellingerhout D, Puduvalli VK. Papillary endothelial hyperplasia presenting as recurrent malignant glioma. J Neurooncol 102(3):491-498, 2011. PMID: 20740304.
- Shon SM, Park JH, Nahrendorf M, Schellingerhout D, Kim JY, Kang BT, Jeong SW, Kim EJ, Ryu JH, Kim K, Kwon IC, Lee DK, Lee MM, Kim DE. Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque. Atherosclerosis 216(1):67-73, 2011. PMID: 21334624.
- Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol 196(2):W187-193, 2011. PMID: 21257861.
- Kim DE, Park KJ, Schellingerhout D, Jeong SW, Ji MG, Choi WJ, Tak YO, Kwan GH, Koh EA, Noh SM, Jang HY, Kim TY, Jeong JW, Lee JS, Choi HK. A new image-based stroke registry containing quantitative magnetic resonance imaging data. Cerebrovasc Dis 32(6):567-576, 2011. PMID: 22104691.
- Muzzafar S, Ketonen L, Weinberg JS, Schellingerhout D. Imaging and clinical features of an intra-axial brain stem schwannoma. AJNR Am J Neuroradiol 31(3):567-569, 2010. PMID: 19833800.
- Kim DE, Kim JY, Schellingerhout D, Kim EJ, Kim HK, Lee S, Kim K, Kwon IC, Shon SM, Jeong SW, Im SH, Lee DK, Lee MM, Kim GE. Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging. Arterioscler Thromb Vasc Biol 30(3):449-456, 2010. PMID: 20056915.
- Schellingerhout D, Le Roux LG, Bredow S, Gelovani JG. Fluorescence imaging of fast retrograde axonal transport in living animals. Mol Imaging 8(6):319-329, 2009. PMID: 20003890.
- Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, Kim WK. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. Mol Imaging 8(5):291-301, 2009. PMID: 19796606.
- Debnam JM, Schellingerhout D, Kumar AJ, Ketonen L, Shah K, Hamberg LM, Hunter GJ. Multidetector CT-guided lumbar puncture in patients with cancer. Interv Neuroradiol 15(1):61-66, 2009. PMID: 20465930.
- Debnam JM, Schellingerhout D. Focal cement accumulation in lytic metastatic lesions: a new sign in vertebroplasty?. Interv Neuroradiol 14(4):465-470, 2008. PMID: 20557749.
- Le Roux LG, Volgin A, Maxwell D, Ishihara K, Gelovani J, Schellingerhout D. Optimizing imaging of three-dimensional multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy. Mol Imaging 7(5):214-221, 2008. PMID: 19123991.
- Mortenson MM, Evans DB, Lee JE, Hunter GJ, Schellingerhout D, Vu T, Edeiken BS, Feng L, Perrier ND. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg 206(5):888-896, 2008. PMID: 18471717.
- Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, Shapiro SE, Edeiken BS, Truong MT, Evans DB, Lee JE, Perrier ND. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 140(6):932-940; discussion 940-941, 2006. PMID: 17188140.
- Kim DE, Tsuji K, Kim YR, Mueller FJ, Eom HS, Snyder EY, Lo EH, Weissleder R, Schellingerhout D. Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging. Radiology 241(3):822-830, 2006. PMID: 17114629.
- Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh JH, Ellis TL, Stieber VW, Asher AL, Fraser RW, Billingsley JS, Lewis P, Schellingerhout D, Shaw EG, Shaw EG. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 105(3):375-384, 2006. PMID: 16961129.
- Mullins ME, Lev MH, Schellingerhout D, Gonzalez RG, Schaefer PW. Intracranial hemorrhage complicating acute stroke: how common is hemorrhagic stroke on initial head CT scan and how often is initial clinical diagnosis of acute stroke eventually confirmed?. AJNR Am J Neuroradiol 26(9):2207-2212, 2005. PMID: 16219823.
- Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH. Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 25(2):226-233, 2005. PMID: 15678125.
- Kim DE, Schellingerhout D, Ishii K, Shah K, Weissleder R. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke 35(4):952-957, 2004. PMID: 14988578.
- Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R. In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 64(5):1579-1583, 2004. PMID: 14996712.
- Schellingerhout D, Lev MH, Bagga RJ, Rincon S, Berdichevsky D, Thangaraj V, Gonzalez RG, Alpert NM. Coregistration of head CT comparison studies: assessment of clinical utility. Acad Radiol 10(3):242-248, 2003. PMID: 12643550.
- Schellingerhout D, Accorsi R, Mahmood U, Idoine J, Lanza RC, Weissleder R. Coded aperture nuclear scintigraphy: a novel small animal imaging technique. Mol Imaging 1(4):344-353, 2002. PMID: 12926230.
- Chew FS, Schellingerhout D, Keel SB. Primary lymphoma of skeletal muscle. AJR Am J Roentgenol 172(5):1370, 1999. PMID: 10227519.
- Chew FS, Schellingerhout D, Keel SB. Late tracheal compression complicating plombage. AJR Am J Roentgenol 172(2):372, 1999. PMID: 9930785.
- Schellingerhout D, Jr BA, Marecos E, Spear M, Breakefield X, Weissleder R. Mapping the in vivo distribution of herpes simplex virions. Hum Gene Ther 9(11):1543-1549, 1998. PMID: 9694153.
Invited Articles
- Najjar AM, Johnson JM, Schellingerhout D. The Emerging role of Amino Acid PET in Neuro-Oncology. Bioengineering (Basel) 5(4), 2018. PMID: 30487391.
- Le Roux LG, Schellingerhout D. Molecular neuroimaging: the basics. Seminars in Roentgenol 49(2):225-233, 2014. PMID: 24836496.
- Debnam JM, Schellingerhout D. Diffusion MR Imaging of the Brain in Patients with Cancer. Int J Mol Imaging 2011:714021, 2011. e-Pub 2011. PMID: 22121483.
- Lee DK, Nahrendorf M, Schellingerhout D, Kim DE. Will molecular optical imaging have clinically important roles in stroke management, and how?. J Clin Neurol 6(1):10-18, 2010. PMID: 20386638.
- Schellingerhout D, Gelovani J. Clinical trials in a molecular world. Neuroimaging Clin N Am 16(4):681-694, 2006. PMID: 17148026.
- Schellingerhout D. Molecular imaging of novel cell- and viral-based therapies. Neuroimaging Clin N Am 16(4):655-679, 2006. PMID: 17148025.
- Schellingerhout D, Josephson L. Molecular imaging of cell-based therapies. Neuroimaging Clin N Am 14(2):331-342, 2004. PMID: 15182822.
- Schellingerhout D, Jr BA. Viral imaging in gene therapy noninvasive demonstration of gene delivery and expression. Neuroimaging Clin N Am 12(4):571-581, 2002. PMID: 12687912.
Other Articles
- Schellingerhout D, Jacobsen MC, Le Roux LG Dual-Energy CT of the Nervous System. American Roentgen Ray Society Categorical Course for Proceedings, Chapter C. EMID: 0f15ea3d95deea01, 2021. PMID: None.
- Gates EDH, Lin JS, Weinberg JS, Prabhu SS, Hamilton J, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes DT, D|| S Advanced magnetic resonance imaging based algorithm for local grading of glioma (Conference Paper). Progress in Biomedical Optics and Imaging - Proceedings of SPIE Volume 11314, 2020. PMID: None.
- Gates, E, Pauloski, JG, Schellingerhout, D, Fuentes, D Glioma segmentation and a simple accurate model for overall survival prediction. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) Volume 11384 LNCS:476-484, 2019. PMID: None.
- Bakas S, Reyes M, Int E, Menze, B Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, and Overall Survival Prediction in the BRATS Challenge, arXiv preprint arXiv:1811.02629. None, 2018. PMID: None.
- Raslan O, Ketonen LM, Fuller GN, Schellingerhout D Intracranial Rosai-Dorfman disease with relapsing spinal lesions. J Clin Oncol 26(18):3087-3089, 2008. PMID: 18565897.
- Koralnik IJ, Schellingerhout D, Frosch MP Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med 350(18):1882-1893, 2004. PMID: 15115835.
- Mullins ME, Lev MH, Schellingerhout D, Koroshetz WJ, Gonzalez RG Influence of availability of clinical history on detection of early stroke using unenhanced CT and diffusion-weighted MR imaging. AJR Am J Roentgenol 179(1):223-228, 2002. PMID: 12076941.
- Schellingerhout D, Chew FS, Mullins ME, Gonzalez RG Projected digital radiologic images for teaching: balance of image quality with data size constraints. Acad Radiol 9(2):157-162, 2002. PMID: 11918368.
- Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R Quantitation of HSV mass distribution in a rodent brain tumor model. Hum Gene Ther 7(19):1648-1655, 2000. PMID: 11083473.
Abstracts
- D|| S. Using a Machine Learning Algorithm as a Prognostic in Glioma Patients. ASFNR Artificial Intelligence Workshop, 2022. PMID: None.
- Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring In Vivo Neural Imaging as a Readout for HDAC6 Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Peripheral Nerve society. Virtual, 2021. PMID: None.
- Le Roux LG, Qiu X, Jacobsen M, Piwnica-Worms D, Schellingerhout D. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Abstract # 3546796. The Association for Research in Vision and Ophthalmology (ARVO), 2021. PMID: None.
- Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring In Vivo Neural Imaging as a Readout for Histone Deacetylase 6 Inhibitor Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Abstract ID: GA451. Virtual World Molecular Imaging Conference, 2020. PMID: None.
- Gates E, Suki D, Weinberg J, Fuentes D, Schellingerhout D. Prognostic Value of Imaging-Based Estimates of Glioma Pathology Pre- and Post-Surgery. E-poster. Joint AAPM/COMP annual meeting, virtual, 2020. PMID: None.
- Gates E, Suki D, Weinberg J, Fuentes D, Schellingerhout D. Prognostic Value of Imaging-Based Estimates of Glioma Pathology Pre- and Post-Surgery, Plenary talk. NLM national trainee conference, virtual, 2020. PMID: None.
- Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Next Generation Pain Therapeutics: From Discovery to the Clinic. Gulf Coast Consortium (canceled due to Covid), 2020. PMID: None.
- Gates, E, Weinberg, J, Lin S, Prabhu S, Hamilton, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Combination of MRI Sequences Predicts Cellular Density in Glioma. American Medical Informatics Association Virtual Summit, Houston, TX, 2020. PMID: None.
- Gates E, Lin J, Weinberg J, Prabhu S, Hamilton J, Fuller G, Baladandayuthapani V, fuentes D, Schellingerhout D. Magnetic Resonance Imaging Based Model for Grading Glioma. American Medical Informatics Association Annual Symposium, Washington DC, 2019. PMID: None.
- Le Roux L, Qiu X, Jacobsen M, Pagel M, Piwnica-Worms D, Schellingerhout. Axonal Transport as a Clinically Translatable in Vivo Biomarker for Neuropathy. 2019 Cancer Survivorship Research Symposium, 2019. PMID: None.
- Le Roux L, Qiu X, Jacobsen M, Gammon S, Piwnica-Worms D, Schellingerhout. Axonal transport as a clinically translatable in vivo biomarker for neuropathy. 7th State of the Science Cancer Survivorship Research Symposium. MD Anderson Cancer Center, Houston, TX, 2019. PMID: None.
- Gates EDH, Schellingerhout D, Fuentes D. Combination of Multicontrast MRI Estimates Local Glioma Malignancy. Society for Industrial and Applied Mathematics (SIAM) TX-LA section meeting, Dallas, TX, 2019. PMID: None.
- Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring In Vivo Neural Imaging as a Readout for Histone Deacetylase 6 Inhibitor Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Abstract ID: GA451. Virtual World Molecular Imaging Conference, 2019. PMID: None.
- Le Roux L, Qiu X, Jacobsen M, Piwnica-Worms D, Schellingerhout. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. . First Annual Gulf Coast Consortium, Translational Imaging Symposium, 2019. PMID: None.
- Le Roux L, Datar V, Jason H, Schott NJ, Armol G, David G, Schellingerhout D. Neurographic Imaging of Radiation Induced Spinal Cord Injury. World Molecular Imaging Congress, Montréal, Canada, 2019. PMID: None.
- Le Roux L, Qiu X, Jacobsen M, Piwnica-Worms D, Schellingerhout D. In Vivo Neural Imaging: |The Impact of Retinal Neuropathy on Axonal Transport. World Molecular Imaging Congress, Montréal, Canada, 2019. PMID: None.
- Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring in vivo neural imaging as a readout for histone deacetylase 6 inhibitor rescue of axonal transport after oxaliplatin-induced peripheral neuropathy. World Molecular Imaging Congress, Montréal, Canada, 2019. PMID: None.
- Gates E, Lin J, Weinberg J, Fuentes D, Schellingerhout. Guiding the First Biopsy in Glioma Patients Using Estimated Ki-67 Maps Derived from MRI. National Library of Medicine Training Conference, Indianapolis IN, 2019. PMID: None.
- Le Roux L, Datar V, Jason H, Schott NJ, Armol G, David G, Schellingerhout D. Neurographic Imaging of Radiation Induced Spinal Cord Injury. Cancer Systems Imaging Annual Retreat, The University of Texas at MD Anderson Cancer Center, Cancer Systems Imaging, Galveston, TX, 2019. PMID: None.
- Le Roux L, Qiu X, Jacobsen M, Datar V, Piwnica-Worms D, Schellingerhout D. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Cancer Systems Imaging Annual Retreat, The University of Texas at MD Anderson Cancer Center, Cancer Systems Imaging, Galveston, TX, 2019. PMID: None.
- Datar V, Le Roux L, Huse J, Niedzielski JS, Ghia A, Grosshans D, Schellingerhout D. Neurographic Imaging of Radiation Induced Spinal Cord Injury. Cancer Systems Imaging Spring Scientific Symposium/Retreat, 2019. PMID: None.
- Gates E, Lin J, Weinberg J, Hamilton J, Prabhu S, Hazle J, Fuller G, Baladandayuthapani V, Fuentes D, Schellingerhout D. Estimated Maps of Proliferative Activity Present Alternative Targets For Initial Glioma Biopsy. 7th Intraoperative Imaging Society Meeting, Houston TX, 2019. PMID: None.
- Jacobsen MC, Cressman E, Duan X, Cody D, Schellingerhout D, Layman R. Limits for Detecting Low Concentrations of Iodine with Dual Energy Computed Tomography. Oral Presentation at the Radiological Society of North America Annual Meeting Chicago, IL, 2018. PMID: None.
- Le Roux LG, Qui X, Jacobsen M, Datar V, Schellingerhout D. Preserving Genital Nerves Function in Prostate Cancer: Imaging guidance with a Molecular Nerve Imaging Agent. World Molecular Imaging Congress, Seattle, Washington, 2018. PMID: None.
- Pauloski JG, Zhang Z, Gates E, Schellingerhout D, Hazle JD, Fuentes D. Optimizing Deep Learning Methods for Image Segmentation with Distributed Training. Texas Advanced Computing Center Symposium for Texas Researchers, 2018. PMID: None.
- Le Roux LG, Qui X, Jacobsen M, Datar V, Piwnica-Worms D, Schellingerhout D. Retinography as a model for Studying Chemotherapy – Induced Neuropathy. World Molecular Imaging Congress, Seattle, Washington, 2018. PMID: None.
- Jacobsen MC, Cressman E, Duan X, Cody D, Schellingerhout D, Layman R. Detecting Iodine Enhancement with Dual-Energy Computed Tomography: How Low Can We Go?. Oral Presentation at the American Association of Physicists in Medicine Annual Meeting; 2018. Nashville, TN, 2018. PMID: None.
- Gate E, Lin J, Weinberg J, Hamilton J, Prabhu S, Hazle J, Fuller G, Baladandayuthapani V, Fuentes D, Schellingerhout D. Quantitative Prediciton of Cellular Proliferation Marker Ki67 Using MR Imaging in Glioma. 60th Annual meeting of the American Association of Physicists in Medicine, 2018. PMID: None.
- Jacobsen MC, Duan X, Cody D, Cressman E, Schellingerhout D, Laymann RR. Determination of the limit of detection for iodinated contrast agents with Multi-Energy Computed Tomography. SPIE Medical Imaging; Houston, Texas, 2018. PMID: None.
- Lin JS, Fuentes D, McCutcheon I, Ferguson S, Prabhu S, Weinburg J, Fuller GN, Hazle JD, Schellingerhout D. Development of a Prediction Technique for Tissue Features using Radiological-Pathological Correlations. The University of Texas MD Anderson Cancer Center Diagnostic Imaging Trainee Research Symposium, 2016. PMID: None.
- Le Roux LG, Qui X, Ramos D, Flores LG, Piwnica-Worms D, Schellingerhout D. Retinography as a Model for Studying Chemotherapy-Induced Neuropathy: Proof of Concept in an Induced Glaucoma Model. Fourth State of the Science Cancer Survivorship Research Symposium, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. PMID: None.
- Le Roux LG, Ramos D, Flores LG, Schellingerhout D. Preserving Genital Nerve Function in Prostate Cancer: Imaging with a Molecular Imaging Agent. Fourth State of the Science Cancer Survivorship Research Symposium. The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. PMID: None.
- Le Roux LG, Vichaya EG, Flores LG, Ramos D, Schellingerhout D. Prevention of Oxaliplatin-Induced Neuropathy by using Minocycline as a Chemoprotectant: Demonstration by Imaging and Behavioral Assessment. Fourth State of the Science Cancer Survivorship Research Symposium, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. PMID: None.
- Le Roux LG, Vichaya EG, Flores LG, Ramos D, Schellingerhout D. Prevention of Oxaliplatin-Induced Neuropathy by using Minocycline as a Chemoprotectant: Demonstration by Imaging and Behavioral Assessment. Conference on Diagnosis, Mechanisms and Management of Cancer Treatment-Induced Neurotoxicities, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. PMID: None.
- Schellingerhout D, Flores L, Gomez D, Le Roux LG. Diabetic Neuropathy Can Be Demonstrated by Molecular Neurographic Imaging and Parallels Neurologic/Behavioral Findings. American Society of Neuroradiology 52nd Annual Meeting. Monteal, Canada. (poster), 2014. PMID: None.
- Garg N, Vining D, Schellingerhout D, Szklaruk J, Raval B, McEnery KW. Intelligent hanging protocols using control flow and regular expressions. Radiological Society of North America 97th Scientific Assembly and Annual Meeting, 2011. PMID: None.
- Schellingerhout D, Le Roux LG, Bredow S. Imaging retrograde neural transport with a molecular probe: neurography. American Society of Neuroradiology Annual Meeting:91, 2011. PMID: None.
- Le Roux LG, Schellingerhout D, Volgin A, Maxwell D, Ishihara K, Gelovani J. Optimizing imaging of 3D multicellular tumor spheroids with fluorescent reporter proteins using confocal micoscopy. 66th Annual Meeting of the Microscopy Society of America. (poster) 14(2):737-735, 2008. PMID: None.
- Raslan O, Schellingerhout D, Ketonen L, Debnam M, Kumar A, Wang J. Stereoscopic visualization of diffusion tensor imaging data. American Association of Physicists in Medicine Annual Meeting 35(6):241, 2008. PMID: None.
- Dagher SA, Gates EDH, Wintermark M, Fuentes DT, Schellingerhout D. The Prognostic Significance of Contrast-Enhanced T1 Signal Intensity in a Large Retrospective Cohort of Adult-Type Diffuse Gliomas. None. PMID: None.
- Dagher SA, Gates EDH, Wintermark M, Long JP, Fuentes DT, Schellingerhout D. The Prognostic Ability of the Ki-67 Proliferation Index Derived from Conventional MRI Sequences and Machine Learning in a Retrospective Cohort of 1179 Gliomas. None. PMID: None.
- Dagher SA, Gates EDH, Wintermark M, Long JP, Fuentes DT, Schellingerhout D. The prognostic value of parametrized Ki-67 maps derived from conventional MRI and machine learning in a large retrospective cohort of adult-type diffuse gliomas. None. PMID: None.
Book Chapters
- Johnson JM, Gule-Monroe MK, Kwon M, Ahmed S, Schellingerhout D, Kumar VA, Edeiken-Monro BS, Debnam JM. Pattern Recognition of Benign and Malignant Thyroid Nodules: Ultrasound Characteristics and Ultrasound-Guided Fine Needle Aspiration of Thyroid Nodules. In: Advanced Thyroid and Parathyroid Ultrasound. None. Springer International Publishing, 179-194, 2017.
- Raslan O, Ketonen L, Fuller G, Schellingerhout D. Central Nervous System Rosai-Dorfman Disease. In: "Methods of Cancer Diagnosis, Therapy and Prognosis.". 1. Springer Company, 392, 2011.
- Kundra V, Schellingerhout, Jackson EF. Targeted and Functional Imaging. In: Targeted Cancer Therapy. Kurzrock R, Markman M. Humana Press, 335-361, 2008.
- Weissleder R, Schellingerhout D. Newer MR Contrast Agents. In: "Radiology: Diagnosis-Imaging-Intervention.". 3. Lippincott-Raven, 1-12, 1997.
Grant & Contract Support
| Title: | (1%), PET/CT and Whole Body Magnetic Resonance Imaging (MRI) in Newly Diagnosed Acute Myeloid Leukemia (AML) |
| Funding Source: | Clinical trial funded by Race Oncology |
| Role: | Co-I |
| Title: | (4%) Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Method for Cancer Imaging Applications |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | (0%). Dual Time Point FDG PET MR Imaging Optimization for the Evaluation of Brain Metastasis (PET-MRI) |
| Funding Source: | UTMDACC Diagnostic Imaging Clinical Research Committee |
| Role: | PI |
| Title: | (0%). A Hyperpolarized Pyruvate MR Spectroscopy Imaging Trial for Glioma Patients: An exploratory first study at MD Anderson Cancer Center |
| Funding Source: | Brain Cancer SPORE Pilot Program |
| Role: | PI |
| Title: | (5%) Machine Learning Estimation of Aggressive Disease to Guide Glioma Prognosis |
| Funding Source: | UTMDACC Institutional Research Grant |
| Role: | Co-PI |
| Title: | (10%). An Information-Theoretic Approach to HP Signal Acquisition In Brain |
| Funding Source: | NIH/NCI |
| Role: | Investigator |
| Title: | (0.5%). Syngo Virtual Operations Cockpit |
| Funding Source: | Siemens Medical Solutions USA |
| Role: | Collaborator |
| Title: | (0%). Study of F18 Fluciclovine PET CT for Assessment of Glioblastoma Tumor Volume and Radiation Response |
| Funding Source: | UTMDACC Diagnostic Imaging Clinical Research Committee |
| Role: | Co-PI |
| Title: | (0%). Advanced CT Imaging Optimization for the Detection of Intracranial Metastasis |
| Funding Source: | UTMDACC Diagnostic Imaging Clinical Research Committee |
| Role: | Collaborator |
| Title: | Advanced CT Imaging Optimization for the Detection of Intracranial Metastasis |
| Funding Source: | Diagnostic Imaging Clinical Research Committee |
| Role: | Collaborator |
| Title: | (10%). Hemorrhagic versus Calcific Brain Lesion Study |
| Funding Source: | GE Healthcare/CABI Award |
| Role: | PI |
| Title: | (0%). Predicting Radiation-Induced Cord Myelopathhy Using a Molecular Imaging Readout of Retrograde Axonal Transport to Predict Myelopathy |
| Funding Source: | Center for Radiation Oncology Research Seed Funding Program |
| Role: | PI |
| Title: | (0%). Development of Unconventional MRI Approaches to Imaging Cancer Immunotherapy |
| Funding Source: | CABI MI2 (Bankson/Sokolov) |
| Role: | Collaborator |
| Title: | (0%). Radiologic Pathologic Correlation on Stereotactic Biopsies in Glioma Patients |
| Funding Source: | MDA IRG Patient Oriented Award |
| Role: | PI |
| Title: | (0%) A New Treatment for Brain Tumors: Targeting Tumor Metabolism with Glucose-based Therapeutic Agents and Monitoring Treatment Response with Hyperpolarized MR-Spectroscopy Recently appointed PI/Coordinator following the departure of Dr. Conrad, after re-writing of the project as: “Targeting the Glycolytic Pathway in the Therapy of Glioma, with Imaging Feedback of Efficacy by Means of Hyperpolarized MR Spectroscopy” |
| Funding Source: | Rose Foundation |
| Role: | PI |
| Title: | (0% support). Molecular Neurographic Imaging to Preserve Genital Nerve Function in Prostate Cancer |
| Funding Source: | MDACC-Washington University p50 Molecular Imaging Center Pilot Project Program |
| Role: | PI |
| Title: | Preserving Genital Nerve Function in Prostate Cancer: Imaging with a Molecular Imaging Agent |
| Funding Source: | M D Anderson Minimally Invasive and New Technology in Oncologic Surgery |
| Role: | Co-I |
| Title: | Reducing the Impact of Chemotherapy-Induced Neuropathies on Cancer Patients: Understanding the Molecular Mechanisms of Disease |
| Funding Source: | Mike Hogg Fund |
| Role: | Co-I |
| Title: | (0% support). Characterization of Calcium and Iron Solutions using Gemstone Spectral Imaging CT to distinguish between Hemorrhagic and Calcific Lesions |
| Funding Source: | Center for Advanced Biomedical Imaging |
| Role: | Co-I |
| Title: | (0%). Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies |
| Funding Source: | MD Anderson Clinical Research Finance Molecular Evaluation and Biopsy Related Support |
| Role: | PI |
| Title: | Molecular Imaging of Retrograde Nerve Transport |
| Funding Source: | NIH/NINDS |
| Role: | PI |
| Title: | (2% effort). Molecular Imaging of Treatments for Oxaliplatin Neurotoxicity |
| Funding Source: | The Mike Hogg Fund |
| Role: | PI |
| Title: | (0%). Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies |
| Funding Source: | MD Anderson Diagnostic Imaging Clinical Research Committee |
| Role: | PI |
| Title: | (0% effort funded). Bridge Funding: Molecular Imaging of Retrograde Nerve Transport |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Title: | Bridge Funding, through chair of Dr. William A Murphy: Molecular Imaging of Retrograde Nerve Transport |
| Funding Source: | John S Dunn, Sr. Distinguished Chair in Diagnostic Imaging |
| Role: | PI |
| Title: | (15% effort). Image Localization for Pathologic Correlation of Delta-24-RGD |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | (20%). Molecular Imaging of Retrograde Nerve Transport |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Principal Investigator-MDACC |
| Title: | (3%). Molecular Imaging of a Nerve Imaging Agent in Rats |
| Funding Source: | The Mike Hogg Fund |
| Role: | PI |
| Title: | Imaging of Stem Cell Recruitment to Stroke |
| Funding Source: | Radiological Society of North America Seed Grant |
| Role: | PI |
| Title: | Imaging Viral Therapy to Brain Tumors |
| Funding Source: | National Brain Tumor Association Fellowship Award |
| Role: | PI |
| Title: | Small Animal Imaging Resource Grant |
| Funding Source: | NIH |
| Role: | Investigator |
| Title: | Viral Gene Delivery to Highly Selective Regions in the Brain through Precision High Frequency Focused Ultrasound |
| Funding Source: | Partners Radiology Research Award |
| Role: | Principal Investigator-MDACC |
| Title: | (20%). Gene Therapy for Brain Tumors: Project 3, Molecular Imaging of Gene Expression |
| Funding Source: | NIH |
| Role: | Investigator |
| Title: | (0%). R-R Variability in Healthy Young Male Human Subjects Undergoing General Anesthesia |
| Funding Source: | NAVKOM Student Investigator Award, NAVKOM |
| Role: | PI |
| Title: | Axonal transport as a biomarker for the early detection and treatment of chemo induced retinopathy |
| Funding Source: | Hesi Thrive Foundation |
| Role: | Co-I |
| Title: | Potentiation of Anti-Angiogenic Therapy by Inhibitors of Energy Metabolism |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | AI-Enabled WHO Grade Estimation to Guide Accurate Biopsy in Gliomas |
| Funding Source: | NIH |
| Role: | Co-I |
| Title: | AI-Enabled Tools For Improving the Brain Cancer Neuroimaging Pipeline |
| Funding Source: | InformAI- NIH SBIR |
| Role: | PI |
| Title: | An Information-theoretic Approach to HP Signal Acquisition in Brain |
| Funding Source: | NIH NCI |
| Role: | Co-PI |
| Title: | Imaging Biomarkers for Glioma: the Stereotactic RadPath Trial |
| Funding Source: | NIH |
| Role: | PI |
| Title: | Imaging-Pathologic and Imaging-Genomic Signatures for Glioma: Establishing Links between Imaging, Pathology and Genomics |
| Funding Source: | NIH |
| Role: | PI |
| Title: | Developing a Molecular Imaging Tool for the Objective Assessment and Monitoring of Chemotherapy-Induced Neuropathy for Clinical Translation |
| Funding Source: | NIH |
| Role: | PI |
| Title: | Imaging and Pathology Quantification of Glioma Heterogeneity |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| Title: | Neurographic Imaging for the Objective Assessment and Monitoring of Chemo-Induced Neuropathy in a Transgenic Mouse Model |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | A Neurographic Imaging Agent to Allow Nerve-sparing Prostate Cancer Treatment |
| Funding Source: | Department of Defense (DOD) Prostate |
| Role: | PI |
| Title: | Combination anti-Vascular and anti-Metabolic Treatments for Brain Tumors with Imaging Guidance by Hyperpolarized MR-Spectroscopy |
| Funding Source: | Marnie Rose Foundation |
| Role: | PI |
| Title: | A Nerve Imaging Agent to Allow Nerve-sparing Prostate Cancer Treatment |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | Developing a Molecular Imaging Tool for Objective Assessment and Monitoring of Chemotherapy-Induced Neuropathy for Clinical Translation |
| Funding Source: | NIH/NEI |
| Role: | PI |
| Title: | Imaging-Pathologic and Imaging-Genomic Signatures for Glioma: Establishing Links between Imaging, Pathology and Genomics |
| Funding Source: | NIH |
| Role: | PI |
| Title: | Neurographic Imaging for the Objective Assessment and Monitoring of Chemo-Induced Neuropathy in a Transgenic Mouse Model |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | The Neuron-Astrocyte Dyad, the Lactate Shuttle and Metabolic Brain Imaging with Hyperpolarized MR |
| Funding Source: | NIH Brain Initiative |
| Role: | PI |
| Title: | Hyperpolarized MR |
| Funding Source: | CPRIT High Risk High Impact LOI |
| Role: | PI |
| Title: | NO TITLE PROVIDED |
| Funding Source: | Brain SPORE Project Solicitation |
| Role: | PI |
| Title: | NO TITLE PROVIDED |
| Funding Source: | Brain Spore Development Research Project |
| Role: | PI |
| Title: | Developing a Molecular Imaging Tool for the Objective Assessment and Monitoring of Chemotherapy-Induced Neuropathy |
| Funding Source: | CPRIT ETRA |
| Role: | PI |
| Title: | An Imaging-Pathologic-Genomic Signature for Glioma: Establishing Links between Imaging, Pathology and Genomics |
| Funding Source: | CPRIT IIRA |
| Role: | PI |
| Title: | NO TITLE PROVIDED |
| Funding Source: | ASNR Comparative Research |
| Role: | PI |
| Title: | Linking Imaging and Biology in Brain Tumors |
| Funding Source: | Moonshot/Translational Research on Brain Tumors |
| Role: | PI |
| Title: | Stereotactic Radiologic-Pathologic Brain Tumor Trial: Correlating Conventional MR, Perfusion, Diffusion, Spectroscopy, Hyperpolarized Spectroscopy and PET Imaging data to Pathology, Immunohistochemistry, Metabolomics, Proteomics and Genomics |
| Funding Source: | CABI MI2 |
| Role: | PI |
| Title: | MR Imaging of Natural Killer Cell Immunotherapy |
| Funding Source: | CPRIT MIRA |
| Role: | PI |
| Title: | Neuroimaging in Cancer Care |
| Funding Source: | NIH R35 |
| Role: | PI |
| Title: | (10%) Understanding the Heterogeneity of Gliomas: Image-Guided biopsy Correlations to Pathology, Metabolomics, Proteomics and Genomics |
| Funding Source: | NIH R01 |
| Role: | PI |
| Title: | A Molecular Imaging Marker to Prevent Radiation Induced Spinal Cord Injury |
| Funding Source: | DoD Spinal Cord Injury |
| Role: | PI |
| Title: | NO TITLE PROVIDED |
| Funding Source: | NIH CIPN |
| Role: | PI |
| Title: | Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy |
| Funding Source: | NIH Spine Radiation |
| Role: | PI |
| Title: | Understanding the Heterogeneity of Gliomas: Image-Guided Biopsy Correlations to Pathology, Metabolomics, Proteomics and Genomics |
| Funding Source: | NIH |
| Role: | PI |
| Title: | Molecular Imaging as a Biomarker for Amyoytrophic Lateral Sclerosis |
| Funding Source: | DoD ALS |
| Role: | PI |
| Title: | Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) IIRA |
| Role: | PI |
| Title: | Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy |
| Funding Source: | DoD Spinal Cord Injury BAA |
| Role: | PI |
| Title: | Retinography: Molecular Imaging to Understand the Mechanisms of Blindness |
| Funding Source: | MDA IRG Basic Science Award |
| Role: | PI |
| Title: | Finding the Borders of Gliomas with Advanced MR Imaging |
| Funding Source: | Brain Spore Developmental Research Grant |
| Role: | PI |
| Title: | Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy |
| Funding Source: | Center for Radiation Oncology Research |
| Role: | PI |
| Title: | Understanding the Molecular Basis of Chemotherapy-Induced Neuropathy Caused by Oxaliplatin |
| Funding Source: | MDA Knowledge Gap Award |
| Role: | Co-I |
| Title: | Advanced MR as a Biomarker for Glioma: Detection, Prognosis and Monitoring |
| Funding Source: | MDA Knowledge Gap Award |
| Role: | PI |
| Title: | Ultrasound-guided Cryoablation of Papillary Thyroid Carcinoma Lymph Node Metastases in the Neck |
| Funding Source: | Thyroid Spore Developmental Research Project |
| Role: | Co-I |
| Title: | Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Preserving Genital Nerve Function in Prostate Cancer: Neurographic Imaging with a Molecular Imaging Agent |
| Funding Source: | CPRIT High Impact/High Risk Research Award |
| Role: | Co-PI |
| Title: | NO TITLE PROVIDED |
| Funding Source: | Howard Hughes Medical Institute (HHMI) |
| Role: | PI |
| Title: | Preserving Genital Nerve Function in Prostate Cancer: Neurographic Imaging with a Molecular Imaging Agent |
| Funding Source: | Prostate Cancer Foundation |
| Role: | PI |
| Title: | (12% effort). Clinically Practical Whole Body MRI of Prostate Cancer Metastasis |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| Title: | (0% effort). Enhancing Quality of Life in Cancer Survivors by using Molecular Imaging to Prevent, Diagnose and Treat Nerve Injury |
| Funding Source: | The University of Texas MD Anderson Survivorship Institutional Grant |
| Role: | PI |
| Title: | Clinically Practical Whole Body MRI of Prostate Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| Title: | (5% effort). DCE/DW-MR and PET/CT Imaging Biomarkers: Optimization, Translation, and Validation |
| Funding Source: | U01 Application |
| Role: | Collaborator |
| Title: | (5% effort). Imaging Retrograde Axonal Transport in Spinal Cord Injury using a Molecular Tracer |
| Funding Source: | Christopher and Dana Reeve Foundation |
| Role: | PI |
| Title: | (10% effort). Spinal Cord Injury Research Program, Exploration-Hypothesis Development Award: Molecular Imaging of Retrograde Nerve Transport in Spinal Cord Injury |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | (20& effort). Molecular Imaging of Nerve Transport |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Imaging Cranial Nerves II, VII and X to Enable Nerve Sparing Cancer Treatments |
| Funding Source: | CPRIT Letter of Intent |
| Role: | PI |
| Title: | (10% effort). Molecular Imaging Technologies to Allow Image Guided Therapy for Cord Tumors |
| Funding Source: | Cord Foundation Research Grant Application |
| Role: | PI |
| Title: | (10% effort). Neurofibromatosis New Investigator Award: Molecular Imaging of Retrograde Nerve Transport in Neurofibromatosis |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | Prostate Cancer Research Program |
| Funding Source: | DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP) |
| Role: | PI |
| Title: | (10% effort). Molecular Imaging of Genital Nerves: Preserving Erectile Function during Prostate Cancer Treatment |
| Funding Source: | Prostate Cancer Foundation |
| Role: | PI |
| Title: | (5% effort). Foundation Fellowship in Basic Science Research: Molecular Imaging of Fast Axonal Transport |
| Funding Source: | Bayer/NER |
| Role: | PI |
| Title: | (5% effort). Neurofibromatosis New Investigator Award: Molecular Imaging of Retrograde Nerve Transport in Neurofibromatosis, Department of Defense (DOD) |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | (20% effort). Outlining the Borders of Gliomas with a Novel Imaging Tracer: [18F]-1-Amino-3-fluoroCycloButane-Carboxylic Acid (FACBC) |
| Funding Source: | Sontag Foundation Career Development Award |
| Role: | PI |
| Title: | Studying the Efficacy of Anti-cancer Drugs using Multi-modality Imaging in Small Animal Models of Cancer: Predicting Early Response to AZD8931 (ErdB2/EGFR Dual Inhibitor) |
| Funding Source: | AstraZeneca |
| Role: | PI |
| Title: | Molecular Imaging of Fast Axonal Transport |
| Funding Source: | Radiological Society of North America Seed Grant |
| Role: | PI |
| Title: | Outlining the Borders of Infiltrative Gliomas with a Novel PET Tracer [18F]-1-Amino-3-fluoroCycloButane-1Carboxylic Acid (FACBC) |
| Funding Source: | Goldhirsch Foundation |
| Role: | PI |
| Title: | Molecular Imaging of Fast Axonal Transport |
| Funding Source: | American Society of Neuroradiology |
| Role: | PI |
| Title: | Developing a Functional Nerve Imaging Agent |
| Funding Source: | Internal Review Board for Texas Advanced Research Program |
| Role: | PI |
| Title: | The Fate of Opsokines Conjugated to Tumor Cells in Rodents |
| Funding Source: | Genetrix, Inc |
| Role: | PI |
| Title: | Molecular Imaging of Fast Axonal Transport |
| Funding Source: | Neuroradiology Educational and Research Foundation, American Society of Neuroradiology |
| Role: | PI |
| Title: | (30%) The Stereotactic Radiology-Pathology Trial II: Prospective Imaging-Pathologic Correlation in Glioma |
| Funding Source: | NIH/NCI |
| Role: | PI |
Patient Reviews
CV information above last modified November 18, 2024